Showing all 2 results
Methyldopa Tablets
FreeMethyldopa Tablets IP 250 mg
Each Film Coated Tablet Contains:
Methyldopa IP eq to Anhydrous Methyldopa 250 mgMethyldopa Tablets IP 500 Mg
Each Film coated Tablet contains:
Methyldopa IP eq to Anhydrous Methyldopa IP 500 mg
Excipients – QSMethyldopa Tablets BP
Each Filmcoated tablet contains :
Methyldopa BP Eq. To Anhydrous Methyldopa 250 mgMETHYLDOPA TABLETS BP 500 MG
Each film coated Tablet contains:
Methyldopa eq to anhydrous Methyldopa BP 500 mg
Excipients – QSUsage: – Treat high blood pressure
Category: – Hypertensive / Cardiac Drugs
Therapeutic category: – Hypertensive
Moxonidine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Micro-Dosed Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active ingredient.
Active Ingredient Strength Primary Clinical Function Moxonidine Ph.Eur./BP 0.2 mg Initiation / Mild Standard: Base therapeutic unit for starting therapy, specifically titrated to assess patient tolerance and prevent initial hypotension. Moxonidine Ph.Eur./BP 0.3 mg / 0.4 mg Global Cardiology Standard: High-efficacy adult maintenance dose for the aggressive management of resistant and metabolic hypertension. Excipients Lactose Monohydrate / Povidone K30 / Crospovidone / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Superdisintegrant / Lubricant (Engineered specifically using strict geometric dilution protocols to ensure the microscopic API dose is flawlessly and evenly distributed throughout the entire tablet batch) *Pack Sizes: 10×10 Blisters or 28/30-Tablet Calendar Packs (Optimized specifically for strict chronic cardiology dispensing regimens).
